Ocular Therapeutix Inc
NASDAQ:OCUL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ocular Therapeutix Inc
NASDAQ:OCUL
|
US |
|
Lithium Energy Ltd
ASX:LEL
|
AU |
|
Appia Rare Earths & Uranium Corp
OTC:APAAF
|
CA |
|
B
|
Bright Packaging Industry Berhad
KLSE:MBRIGHT
|
MY |
|
N
|
Nutex Befektetesi Nyrt
BET:NUTEX
|
HU |
|
R
|
Roots Corp
F:4RO
|
CA |
|
N
|
Netscout Systems Inc
F:NSZ
|
US |
|
M
|
Mitra Adiperkasa Tbk PT
SWB:QGI
|
ID |
|
N
|
Nasdaq Inc
XMUN:NAQ
|
US |
|
Gold Flora Corp
OTC:GRAM
|
US |
|
Dimerix Ltd
ASX:DXB
|
AU |
|
Zhejiang Hangmin Co Ltd
SSE:600987
|
CN |
|
S
|
Surteco Group SE
F:SUR
|
DE |
Bankruptcy Probability
Ocular Therapeutix Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Ocular Therapeutix Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Ocular Therapeutix Inc
NASDAQ:OCUL
|
2.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
650.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
362.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
354B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
220.7B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
194.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
288.8B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
157.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
128.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Ocular Therapeutix Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Ocular Therapeutix Inc has total debt of 72.8m USD. This includes both short-term (0 USD) and long-term (72.8m USD) debt.
You can find a full breakdown on its Balance Sheet.